MEMORIAL DAY OFFER 50% OFF Premium Subscription Order Now MEMORIAL DAY 50% OFF Subscription >>

No Pain, No Gain.Week 21 On Stock Market Click to watch.

Bellicum Pharmaceuticals Stock Forecast

NASDAQ:BLCM BUY SELL

$1.46 (8.15%)

Volume: 23.047k

Closed: May 27, 2022

Hollow Logo Score: -2.594

Bellicum Pharmaceuticals Stock Forecast

BUY SELL NASDAQ:BLCM
$1.46 (8.15%)

Volume: 23.047k

Closed: May 27, 2022

Score Hollow Logo -2.594

Bellicum Pharmaceuticals Stock Forecast NASDAQ:BLCM

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-02-16 242.47% Ladenburg Thalmann $5.00 Initiates Coverage On Buy
2020-10-30 208.22% Wells Fargo $4.50 Downgrades Overweight Equal-Weight
2020-03-13 1064.38% Raymond James $40.00 $17.00 Maintains Outperform

BLCM Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -15.71% during the next 3 months and, with a 90% probability hold a price between $1.07 and $1.63 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-06-01 $1.26 $1.60 $1.93
2022-06-02 $1.26 $1.59 $1.92
2022-06-03 $1.25 $1.58 $1.91
2022-06-06 $1.25 $1.58 $1.91
2022-06-07 $1.24 $1.57 $1.90
2022-06-08 $1.24 $1.57 $1.90
2022-06-09 $1.23 $1.56 $1.89
2022-06-10 $1.22 $1.56 $1.89
2022-06-13 $1.22 $1.55 $1.88
2022-06-14 $1.21 $1.54 $1.87
2022-06-15 $1.21 $1.54 $1.87
2022-06-16 $1.20 $1.53 $1.86
2022-06-17 $1.20 $1.53 $1.86
2022-06-21 $1.19 $1.52 $1.85
2022-06-22 $1.18 $1.52 $1.85
2022-06-23 $1.18 $1.51 $1.84
2022-06-24 $1.17 $1.50 $1.83
2022-06-27 $1.17 $1.50 $1.83
2022-06-28 $1.16 $1.49 $1.82
2022-06-29 $1.16 $1.49 $1.82
2022-06-30 $1.15 $1.48 $1.81
2022-07-01 $1.14 $1.48 $1.81
2022-07-05 $1.14 $1.47 $1.80
2022-07-06 $1.13 $1.46 $1.79
2022-07-07 $1.13 $1.46 $1.79
2022-07-08 $1.12 $1.45 $1.78
2022-07-11 $1.12 $1.45 $1.78
2022-07-12 $1.11 $1.44 $1.77
2022-07-13 $1.10 $1.44 $1.77
2022-07-14 $1.10 $1.43 $1.76

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers, solid tumors, and orphan inherited blood disorders in the United States and internationally. Its clinical product candidate is BPX-501, an adjunct T-cell therapy in multiple Phase I/II clinical trials, administered after allogeneic hematopoietic stem cell trans... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT